Cargando…
Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412175/ https://www.ncbi.nlm.nih.gov/pubmed/37565162 http://dx.doi.org/10.1155/2023/9867930 |
| _version_ | 1785086833465491456 |
|---|---|
| author | Longevity, Oxidative Medicine and Cellular |
| author_facet | Longevity, Oxidative Medicine and Cellular |
| author_sort | Longevity, Oxidative Medicine and Cellular |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10412175 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104121752023-08-10 Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer Longevity, Oxidative Medicine and Cellular Oxid Med Cell Longev Retraction Hindawi 2023-08-02 /pmc/articles/PMC10412175/ /pubmed/37565162 http://dx.doi.org/10.1155/2023/9867930 Text en Copyright © 2023 Oxidative Medicine and Cellular Longevity. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Longevity, Oxidative Medicine and Cellular Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer |
| title | Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer |
| title_full | Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer |
| title_fullStr | Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer |
| title_full_unstemmed | Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer |
| title_short | Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer |
| title_sort | retracted: network pharmacology, molecular docking, and experimental validation to unveil the molecular targets and mechanisms of compound fuling granule to treat ovarian cancer |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412175/ https://www.ncbi.nlm.nih.gov/pubmed/37565162 http://dx.doi.org/10.1155/2023/9867930 |
| work_keys_str_mv | AT longevityoxidativemedicineandcellular retractednetworkpharmacologymoleculardockingandexperimentalvalidationtounveilthemoleculartargetsandmechanismsofcompoundfulinggranuletotreatovariancancer |